Cargando…

Oral versus intravenous administration of cyclophosphamide: a case report

BACKGROUND: Cyclophosphamide, an alkylating agent, has been used as an immunosuppressant in the treatment of various autoimmune disorders and malignancies. It is highly capable of reducing T and B lymphocytes. CASE PRESENTATION: Regular blood tests are important to detect bone marrow suppression. Th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Kenneth S, Kwok, Chung, Lok, Aishin
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2008
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2615431/ https://www.ncbi.nlm.nih.gov/pubmed/19077308 http://dx.doi.org/10.1186/1757-1626-1-395

Ejemplares similares

Water Intoxication Following Low-Dose Intravenous Cyclophosphamide
por: Koo, Tai Yeon, et al.
Publicado: (2007)

Two Cases of Refractory Thrombocytopenia in Systemic Lupus Erythematosus that Responded to Intravenous Low-Dose Cyclophosphamide
por: Park, Hee-Jin, et al.
Publicado: (2013)

Cyclophosphamide: Death: case report
Publicado: (2021)

Cyclophosphamide: Thrombocytopenia: case report
Publicado: (2021)

Cyclophosphamide: Lack of efficacy: case report
Publicado: (2020)

Marked improvement of Churg–Strauss syndrome neuropathy by intravenous immunoglobulin and cyclophosphamide
por: Umeda, Akira, et al.
Publicado: (2014)

Successful Treatment with Intravenous Cyclophosphamide for Refractory Adult-Onset Still's Disease
por: Tsuji, Yoshika, et al.
Publicado: (2015)

Severe Enteritis after Cyclophosphamide Administration in a Patient with Microscopic Polyangiitis: A Case Report and Literature Review
por: Yoshida, Shuhei, et al.
Publicado: (2022)

A Randomized Controlled Trial of Intravenous versus Oral Cyclophosphamide in Steroid-resistant Nephrotic Syndrome in Children
por: Shah, K. M., et al.
Publicado: (2017)

Cyclophosphamide/prednisone: Various infections: case report
Publicado: (2021)

Cyclophosphamide/methylprednisolone/prednisone: No improvement: case report
Publicado: (2022)

A Case of Refractory Hypothyroidism due to Poor Compliance Treated with the Weekly Intravenous and Oral Levothyroxine Administration
por: Nakano, Yujiro, et al.
Publicado: (2019)

Intravenous Cyclophosphamide for Gastric Antral Vascular Ectasia Associated with Systemic Sclerosis Refractory to Endoscopic Treatment: A Case Report and Review of the Pertinent Literature
por: Matsumoto, Yuki, et al.
Publicado: (2018)

Systemic AA Amyloidosis Associated With Intravenous Injection of Oral Prescription Opioids—An Autopsy Case Report
por: Zabel, Kenneth M., et al.
Publicado: (2022)

Carnitine/cyclophosphamide/lactulose: Various toxicities: case report
Publicado: (2019)

Cyclophosphamide/methylprednisolone/prednisolone: Multiple infections: case report
Publicado: (2021)

Cyclophosphamide/docetaxel/pegfilgrastim: Various toxicities: case report
Publicado: (2021)

Cyclophosphamide/rituximab: COVID-19 infection: case report
Publicado: (2021)

Cyclophosphamide/methylprednisolone: COVID-19 infection: case report
Publicado: (2021)

Sustained Treatment Response after Intravenous Cyclophosphamide in a Patient with Therapy-Resistant COVID-19 Acute Respiratory Distress Syndrome: A Case Report
por: Haselwanter, Patrick, et al.
Publicado: (2023)

Oral cyclophosphamide-induced posterior reversible encephalopathy syndrome in a patient with ANCA-associated vasculitis: A case report
por: Kim, Yire, et al.
Publicado: (2021)

Long-term Effects of Intravenous Cyclophosphamide in Combination with Mesna Provided Intravenously and via Bladder Perfusion in a Patient with Severe Multifocal Motor Neuropathy
por: Iwasawa, Eri, et al.
Publicado: (2017)

Coronary spastic angina after the administration of intravenous immunoglobulin in myasthenia gravis: a case report
por: Yanagihashi, Masaru, et al.
Publicado: (2020)

Patient-reported preferences for oral versus intravenous administration for the treatment of cancer: a review of the literature
por: Eek, Daniel, et al.
Publicado: (2016)

Intravenous buprenorphine/naloxone and concomitant oral pregabalin misuse: a case report
por: Kulaksızoğlu, Burak, et al.
Publicado: (2018)

Interstitial pneumonia induced by cyclophosphamide: A case report and review of the literature
por: Qian, Panpan, et al.
Publicado: (2019)

Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy.
por: Loh, C. S., et al.
Publicado: (1993)

Differential Metabolism of Glycerol Based on Oral versus Intravenous Administration in Humans
por: Shah, Ankit, et al.
Publicado: (2022)

Bevacizumab with metronomic chemotherapy of low-dose oral cyclophosphamide in recurrent cervical cancer: Four cases
por: Isono-Nakata, Rose, et al.
Publicado: (2018)

Intravenous zoletil administration for the purpose of suicide
por: Cha, Kyungman, et al.
Publicado: (2021)

A case of intravenous iron administration resulting in cerebral edema expansion
por: Espinosa, Jonathan, et al.
Publicado: (2023)

Visceral metastatic angiosarcoma treated effectively with oral cyclophosphamide combined with propranolol
por: Daguzé, Justine, et al.
Publicado: (2016)

Cyclophosphamide/prednisolone/rituximab: Nosocomial COVID-19 infection: case report
Publicado: (2020)

Low-dose “metronomic chemotherapy” with oral cyclophosphamide and methotrexate in metastatic breast cancer: a case report of extraordinarily prolonged clinical benefit
por: Masci, G, et al.
Publicado: (2012)

Severe oral and intravenous insecticide mixture poisoning with diabetic ketoacidosis: a case report
por: Badrane, Narjis, et al.
Publicado: (2014)

Cyclophosphamide-induced posterior reversible encephalopathy syndrome (PRES): a case report
por: Jayaweera, Jayamalee L, et al.
Publicado: (2014)

Metronomic chemotherapy with cyclophosphamide for the treatment of advanced hepatocellular cancer: A case report
por: Peristeri, Dimitra V., et al.
Publicado: (2021)

Intractable Hemophagocytic Syndrome Associated with Systemic Lupus Erythematosus Resistant to Corticosteroids and Intravenous Cyclophosphamide That Was Successfully Treated with Cyclosporine A
por: Toko, Hirofumi, et al.
Publicado: (2018)

Prevention of the exposure by cyclophosphamide oral tablet
por: Hanada, Takae, et al.
Publicado: (2015)

A case of doxorubicin and cyclophosphamide therapy-induced type 1 diabetes: a case report
por: Miyabayashi, Makoto, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2ugo48530l601cluj2ruent8qc